The rise of the plasma lipid concentration elicited by dietary sodium chloride restriction in Wistar rats is due to an impairment of the plasma triacylglycerol removal rate

被引:21
作者
Catanozi, S
Rocha, JC
Nakandakare, ER
Passarelli, M
Mesquita, CH
Silva, AA
Dolnikoff, MS
Harada, LM
Quintao, ECR
Heimann, JC
机构
[1] Univ Sao Paulo, Sch Med, Lipids Lab LIM 10, BR-01246903 Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Expt Hypertens Lab LIM 16, BR-05508 Sao Paulo, Brazil
[3] Univ Sao Paulo, Nucl Res Inst, BR-05508 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
salt restriction; Triton-WR; 1339; triacylglycerol synthesis; plasma lipoprotein kinetics; hypertriglyceridemia; hyperlipidemia;
D O I
10.1016/S0021-9150(01)00415-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies in humans have indicated that dietary salt restriction raises plasma levels of total cholesterol (TC) and triacylglycerols (TAG). In order to explain the mechanisms involved, a rat experimental model was developed consisting of chronic feeding ad libitum isocaloric diets with variable sodium chloride contents. Rates of synthesis of plasma TAG were measured either as the increase of plasma TAG after blocking its removal from plasma by the intra-arterial pulse infusion of Triton-WR 1339, or as the plasma rate of incorporation of [C-14]-oleic acid [C-14]-TAG. Plasma TAG removal rate was determined by the intra-arterial pulse infusion of a lipid emulsion. Severe salt restriction increased the plasma concentrations of TAG (71%) and of TC (10%). This result was not due to modification of the rate of synthesis of plasma TAG but was attributed to a 55% slower rate of removal of the TAG-containing lipoproteins. An increased plasma non-esterified fatty acid concentration, probably due to a salt restriction-related insulin resistance, may have impaired the activity of the enzyme lipoprotein lipase. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 62 条
[1]   THE EFFECTS OF ANTIHYPERTENSIVE DRUGS ON SERUM-LIPIDS AND LIPOPROTEINS .1. DIURETICS [J].
AMES, RP .
DRUGS, 1986, 32 (03) :260-278
[2]  
[Anonymous], 1988, ARCH INTERN MED, V148, P1023
[3]   PLASMA TRIGLYCERIDE AND CORONARY HEART-DISEASE [J].
AUSTIN, MA .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :2-14
[4]  
BAKER N, 1964, J LIPID RES, V5, P188
[5]   TISSUE EFFECTS OF GLUCOCORTICOIDS [J].
BAXTER, JD ;
FORSHAM, PH .
AMERICAN JOURNAL OF MEDICINE, 1972, 53 (05) :573-+
[6]   LIPOPROTEIN-LIPASE - MECHANISM OF PRODUCT INHIBITION [J].
BENGTSSON, G ;
OLIVECRONA, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1980, 106 (02) :557-562
[7]   TRIACYLGLYCEROL SECRETION IN RATS - VALIDATION OF A TRACER METHOD EMPLOYING RADIOACTIVE GLYCEROL [J].
BIRD, M ;
WILLIAMS, MA ;
BAKER, N .
JOURNAL OF NUTRITION, 1984, 114 (10) :1978-1985
[8]  
Bjorntorp Per, 1994, Current Opinion in Lipidology, V5, P166, DOI 10.1097/00041433-199405030-00003
[9]   EFFECT OF VARIATIONS IN DIETARY-SODIUM INTAKE ON SODIUM-EXCRETION IN MATURE RATS [J].
BRENSILVER, JM ;
DANIELS, FH ;
LEFAVOUR, GS ;
MALSEPTIC, RM ;
LORCH, JA ;
PONTE, ML ;
CORTELL, S .
KIDNEY INTERNATIONAL, 1985, 27 (03) :497-502
[10]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838